{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:21:09Z","timestamp":1784290869104,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Science and Technology Department of Hunan Province","award":["2013FJ4087"],"award-info":[{"award-number":["2013FJ4087"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.clinbiochem.2013.08.019","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T22:16:07Z","timestamp":1378419367000},"page":"1705-1708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay"],"prefix":"10.1016","volume":"46","author":[{"given":"Jingjing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinbiochem.2013.08.019_bb0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2012.09.003","article-title":"Human epididymis protein 4 (HE4) and ovarian cancer prognosis","volume":"127","author":"Trudel","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"Pt 1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj20020869","article-title":"A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein","volume":"368","author":"Clauss","year":"2002","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.clinbiochem.2013.08.019_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erm.09.39","article-title":"HE4 as a biomarker for ovarian and endometrial cancer management","volume":"9","author":"Li","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2012.10.036","article-title":"Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis","volume":"167","author":"Lin","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2013.08.019_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2012.11.026","article-title":"Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome","volume":"128","author":"Sandri","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3892\/ol.2013.1339","article-title":"Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer","volume":"6","author":"Yang","year":"2013","journal-title":"Oncol Lett"},{"issue":"8","key":"10.1016\/j.clinbiochem.2013.08.019_bb0035","doi-asserted-by":"crossref","first-page":"15636","DOI":"10.3390\/ijms140815636","article-title":"Exploring the glycosylation of serum CA125","volume":"14","author":"Saldova","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.clinbiochem.2013.08.019_bb0040","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2013.08.019_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13277-009-0015-y","article-title":"HE4: a new potential early biomarker for the recurrence of ovarian cancer","volume":"31","author":"Anastasi","year":"2010","journal-title":"Tumour Biol"},{"issue":"8","key":"10.1016\/j.clinbiochem.2013.08.019_bb0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clinbiochem.2013.08.019_bb0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2013.08.019_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/CCLM.2011.075","article-title":"The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?","volume":"49","author":"Montagnana","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.clinbiochem.2013.08.019_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2013.08.019_bb0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","article-title":"Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass","volume":"127","author":"Karlsen","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.clinbiochem.2013.08.019_bb0080","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1757-2215-5-20","article-title":"High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer","volume":"5","author":"Kalapotharakos","year":"2012","journal-title":"J Ovarian Res"},{"issue":"5","key":"10.1016\/j.clinbiochem.2013.08.019_bb0090","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s13277-012-0440-1","article-title":"An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions","volume":"33","author":"Macuks","year":"2012","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.clinbiochem.2013.08.019_bb0095","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s13277-012-0499-8","article-title":"Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression","volume":"33","author":"Yamashita","year":"2012","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13277-012-0583-0","article-title":"The role of novel biomarker HE4 in endometrial cancer: a case control prospective study","volume":"34","author":"Angioli","year":"2013","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2013.08.019_bb0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bios.2012.01.004","article-title":"Ultrasensitive electrochemical immunosensor for HE4 based on rolling circle amplification","volume":"33","author":"Lu","year":"2012","journal-title":"Biosens Bioelectron"},{"issue":"5","key":"10.1016\/j.clinbiochem.2013.08.019_bb0115","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/toxins5050865","article-title":"An ultrasensitive electrochemiluminescent immunoassay for aflatoxin M1 in milk, based on extraction by magnetic graphene and detection by antibody-labeled CdTe quantumn dots-carbon nanotubes nanocomposite","volume":"5","author":"Gan","year":"2013","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/j.clinbiochem.2013.08.019_bb0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10815-012-9923-7","article-title":"A highly sensitive electrochemiluminescence immunoassay for detecting human embryonic human chorionic gonadotropin in spent embryo culture media during IVF-ET cycle","volume":"30","author":"Xiao-Yan","year":"2013","journal-title":"J Assist Reprod Genet"},{"issue":"Pt 1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1258\/acb.2008.008170","article-title":"Reference intervals: the way forward","volume":"46","author":"Ceriotti","year":"2009","journal-title":"Ann Clin Biochem"},{"issue":"16","key":"10.1016\/j.clinbiochem.2013.08.019_bb0130","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.clinbiochem.2011.08.1137","article-title":"Reference values for serum ferritin in Chinese Han ethnic males: results from a Chinese male population survey","volume":"44","author":"Li","year":"2011","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.clinbiochem.2013.08.019_bb0135","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.26129","article-title":"Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer","volume":"130","author":"Park","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2013.08.019_bb0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biol"},{"issue":"12","key":"10.1016\/j.clinbiochem.2013.08.019_bb0145","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.7314\/APJCP.2012.13.12.6391","article-title":"Human epididymis protein 4 reference intervals in a multiethnic Asian women population","volume":"13","author":"Mokhtar","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.clinbiochem.2013.08.019_bb0150","doi-asserted-by":"crossref","first-page":"349.e1","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinbiochem.2013.08.019_bb0155","series-title":"Defining, establishing, and verifying reference intervals in the clinical laboratory. Approved guideline","author":"Horowitz","year":"2008"},{"key":"10.1016\/j.clinbiochem.2013.08.019_bb0160","series-title":"NCCLS EP A15: user demonstration of performance for precision and accuracy; approved guideline","year":"2001"},{"issue":"5","key":"10.1016\/j.clinbiochem.2013.08.019_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13277-010-0049-1","article-title":"ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women","volume":"31","author":"Anastasi","year":"2010","journal-title":"Tumour Biol"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013003986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013003986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:41:16Z","timestamp":1757864476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013003986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":33,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0009912013003986"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.08.019","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}